Pharmacokinetic Evaluations of the Co-Administrations of Vandetanib and Metformin, Digoxin, Midazolam, Omeprazole or Ranitidine - Johansson, Susanne; Read, Jessica; Oliver, Stuart; Steinberg, Mark; Li, Yan; Lisbon, Eleanor; Mathews, David; Leese, Philip T.; Martin, Paul (Clinical pharmacokinetics, 2014)
Keywords: Adolescent; Adult; Area Under Curve; Digoxin - adverse effects; Digoxin - blood; Digoxin - pharmacokinetics; Drug Interactions; Female; Humans; Internal Medicine; Male; Medicine; Medicine & Public Health; Metformin - adverse effects; Metformin - blood; Metformin - pharmacokinetics; Midazolam - adverse effects; Midazolam - blood; Midazolam - pharmacokinetics; Middle Aged; Omeprazole - adverse effects; Omeprazole - blood; Omeprazole - pharmacokinetics; Original Research Article; Pharmacology/Toxicology; Pharmacotherapy; Piperidines - adverse effects; Piperidines - blood; Piperidines - pharmacokinetics; Quinazolines - adverse effects; Quinazolines - blood; Quinazolines - pharmacokinetics; Ranitidine - adverse effects; Ranitidine - blood; Ranitidine - pharmacokinetics; Young Adult; Omeprazole; Metformin; Midazolam; Digoxin; Ranitidine